Market Update (NYSE:ABBV): AbbVie to Present Data on Investigational Oncology Compounds at the 56th American Society of Hematology Annual Meeting

[PR Newswire] – NORTH CHICAGO, Ill., Nov. 17, 2014 /PRNewswire/ — AbbVie (NYSE: ABBV) will present data evaluating three investigational compounds from the company’s oncology pipeline at the upcoming 56th American Society … . . . → Read More: Market Update (NYSE:ABBV): AbbVie to Present Data on Investigational Oncology Compounds at the 56th American Society of Hematology Annual Meeting Similar Articles: Market Update: AbbVie Inc (NYSE:ABBV) – ABBVIE (ABBV) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating AbbVie Inc. For Potential Securities Fraud and Breach of Fiduciary Duty Market Update (NYSE:ABBV): AbbVie Reports Third-Quarter 2014 Financial Results Stock Update (NYSE:ABBV): AbbVie files New Drug Submission to Health Canada for its investigational, all-oral, interferon-free therapy for the treatment of hepatitis C